Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lecozotan SR add-on study in mild to moderate Alzheimer's disease
2005-001477-94Phase 2Completed
- Sponsor
- Wyeth
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lecozotan in Alzheimer's disease (AD) (4 arms), sponsored by Wyeth. Primary endpoints: Change from baseline in ADAS-Cog at week 24 and Change from baseline in ADCS-CGIC at week 24. Started Jun 2005; status: completed.
02
Drugs
lecozotan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2005-001477-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001477-94.